Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

MXCTMAXCYTE, INC.

Nasdaq · CIK 0001287098
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC8731 Services-Commercial Physical & Biological Research
FY end1231
XBRL facts240

Identity from submissions API

NameMAXCYTE, INC.
CIK0001287098
TickersMXCT
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC8731 Services-Commercial Physical & Biological Research
EIN522210438
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone301-517-5556
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • MAXCYTE INC (2004-04-14T04:00:00.000Z → 2008-09-18T04:00:00.000Z)
Business address
9713 KEY WEST AVENUE,
SUITE 400
ROCKVILLE
MD
20850
MD
Mailing address
9713 KEY WEST AVENUE,
SUITE 400
ROCKVILLE
MD
20850
MD

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

339 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 4 FORM 4 0000905148-26-005032 5183
2026-11-10 10-Q 10-Q 0001104659-26-125236 001-40674 261540928 34 8021214 1 1
2026-11-10 8-K FORM 8-K 1.01,2.02,3.02,7.01,9.01 0001104659-26-124829 001-40674 261538082 34 11493837 1 1
2026-11-02 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001544204-26-000010 005-92738 261510393 34 7125
2026-10-15 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001544204-26-000009 005-92738 261461498 34 7030
2026-10-14 8-K FORM 8-K 2.02,9.01 0001104659-26-115745 001-40674 261458338 34 235404 1 1
2026-08-13 10-Q 10-Q 0001104659-26-095971 001-40674 261274128 34 7782976 1 1
2026-08-12 8-K 8-K 2.02,7.01,9.01 0001104659-26-094886 001-40674 261267647 34 6942806 1 1
2026-08-04 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001486180-26-000003 005-92738 261235674 34 7635
2026-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002825 005-92738 261216862 34 10839
2026-06-22 4 FORM 4 0000905148-26-003056 7241
2026-06-22 4 FORM 4 0000905148-26-003055 7184
2026-06-22 4 FORM 4 0000905148-26-003054 7193
2026-06-22 4 FORM 4 0000905148-26-003053 7351
2026-06-22 4 FORM 4 0000905148-26-003052 7196
2026-06-22 4 FORM 4 0000905148-26-003051 7217
2026-06-22 4 FORM 4 0000905148-26-003050 7235
2026-06-22 4 FORM 4 0000905148-26-003049 7249
2026-06-17 8-K 8-K 5.07 0001104659-26-075211 001-40674 261099315 34 161703 1 1
2026-06-16 8-K 8-K 3.01 0001104659-26-074594 001-40674 261094923 34 148407 1 1
2026-05-14 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001486180-26-000002 005-92738 26976257 34 7048
2026-05-13 10-Q 10-Q 0001104659-26-060290 001-40674 26973941 34 6284469 1 1
2026-05-12 8-K 8-K 2.02,7.01,9.01 0001104659-26-059399 001-40674 26968672 34 6386154 1 1
2026-04-29 ARS ARS 0001140361-26-017847 001-40674 26917335 34 1920717
2026-04-29 DEFA14A DEFA 14A 0001140361-26-017845 001-40674 26917311 34 3574041
2026-04-29 DEF 14A DEF 14A 0001140361-26-017844 001-40674 26917280 34 3388509 1 1
2026-04-17 4 xslF345X06/form4.xml 0000905148-26-001718 4964
2026-04-15 S-8 FORM S-8 0001104659-26-043814 333-295073 26864374 33 375721 1 1
2026-04-10 4 xslF345X06/form4.xml 0000905148-26-001644 5452
2026-04-10 3 xslF345X06/form3.xml 0000905148-26-001643 10880
2026-04-10 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-001441 005-92738 26853508 34 7851
2026-03-31 4 FORM 4 0000905148-26-001480 7517
2026-03-27 8-K 8-K 5.02,9.01 0001104659-26-036201 001-40674 26808234 34 172272 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001792 005-92738 26802177 34 7282
2026-03-25 10-K 10-K 0001104659-26-034557 001-40674 26792978 34 12287694 1 1
2026-03-24 8-K 8-K 2.02,7.01,9.01 0001104659-26-033867 001-40674 26786397 34 6608258 1 1
2026-03-20 8-K 8-K 3.01 0001104659-26-032761 001-40674 26778765 34 152544 1 1
2026-03-19 4 FORM 4 0000905148-26-001397 5698
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001011438-26-000135 005-92738 26639762 34 10952
2026-02-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001901361-26-000009 005-92738 26600612 34 7070
2026-01-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000694 005-92738 26545880 34 10893
2026-01-12 8-K 8-K 2.02,9.01 0001104659-26-002901 001-40674 26527384 34 187926 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001011438-25-000570 005-92738 251484119 34 11213
2025-11-13 10-Q 10-Q 0001104659-25-111396 001-40674 251479176 34 8330591 1 1
2025-11-12 8-K 8-K 2.02,7.01,9.01 0001104659-25-110375 001-40674 251472874 34 6400053 1 1
2025-11-05 8-K 8-K 2.02,9.01 0001104659-25-107118 001-40674 251455223 34 268460 1 1
2025-11-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-004562 005-92738 251446838 34 7785
2025-11-03 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-004537 005-92738 251442706 34 7640
2025-10-24 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001486180-25-000006 005-92738 251415204 34 6866
2025-09-22 8-K 8-K 2.05,7.01,9.01 0001104659-25-092162 001-40674 251330552 34 188290 1 1
2025-08-27 4 xslF345X05/form4.xml 0000905148-25-003155 5010
2025-08-26 S-8 FORM S-8 0001104659-25-083112 333-289865 251258082 33 218910 1 1
2025-08-13 4 xslF345X05/form4.xml 0000905148-25-002877 4382
2025-08-13 4 xslF345X05/form4.xml 0000905148-25-002876 4900
2025-08-13 4 xslF345X05/form4.xml 0000905148-25-002875 4770
2025-08-13 4 xslF345X05/form4.xml 0000905148-25-002874 4926
2025-08-13 4 xslF345X05/form4.xml 0000905148-25-002873 4286
2025-08-11 8-K 8-K 5.02 0001558370-25-011056 001-40674 251202452 34 152803 1 1
2025-08-06 10-Q 10-Q 0001558370-25-010554 001-40674 251190378 34 8022061 1 1
2025-08-06 8-K 8-K 2.02,7.01,9.01 0001558370-25-010523 001-40674 251189725 34 6507895 1 1
2025-06-25 8-K 8-K 8.01,9.01 0001558370-25-008856 001-40674 251074116 34 151540 1 1
2025-06-25 144 xsl144X01/primary_doc.xml 0001972481-25-000128 001-40674 251073686 33 4502
2025-06-23 4 xslF345X05/form4.xml 0000905148-25-002235 18085
2025-06-23 4 xslF345X05/form4.xml 0000905148-25-002234 18026
2025-06-23 4 xslF345X05/form4.xml 0000905148-25-002233 18027
2025-06-23 4 xslF345X05/form4.xml 0000905148-25-002232 18180
2025-06-23 4 xslF345X05/form4.xml 0000905148-25-002231 6897
2025-06-23 4 xslF345X05/form4.xml 0000905148-25-002230 18463
2025-06-23 4 xslF345X05/form4.xml 0000905148-25-002229 18409
2025-06-23 4 xslF345X05/form4.xml 0000905148-25-002228 18497
2025-06-18 8-K 8-K 5.02,5.07,9.01 0001558370-25-008730 001-40674 251057639 34 1512276 1 1
2025-05-29 DEFA14A DEFA14A 0001104659-25-054280 001-40674 251003902 34 33881
2025-05-08 10-Q 10-Q 0001558370-25-007005 001-40674 25927250 34 6712185 1 1
2025-05-07 8-K 8-K 2.02,7.01,9.01 0001558370-25-006739 001-40674 25921541 34 5787601 1 1
2025-04-28 ARS ARS 0001104659-25-040276 001-40674 25881395 34 2146254
2025-04-28 DEF 14A DEF 14A 0001104659-25-040269 001-40674 25881339 34 3064761 1 1
2025-04-15 PRE 14A PRE 14A 0001104659-25-035155 001-40674 25840187 34 3036930 1 1
2025-03-20 4 xslF345X05/form4.xml 0000905148-25-000986 5458
2025-03-20 4 xslF345X05/form4.xml 0000905148-25-000985 5447
2025-03-20 4 xslF345X05/form4.xml 0000905148-25-000984 5477
2025-03-18 4 xslF345X05/form4.xml 0000905148-25-000964 7238
2025-03-18 4 xslF345X05/form4.xml 0000905148-25-000963 7225
2025-03-18 4 xslF345X05/form4.xml 0000905148-25-000962 7257
2025-03-18 4 xslF345X05/form4.xml 0000905148-25-000961 5373
2025-03-11 10-K 10-K 0001558370-25-002721 001-40674 25728559 34 10983815 1 1
2025-03-11 8-K 8-K 2.02,7.01,9.01 0001558370-25-002708 001-40674 25727780 34 5840948 1 1
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001011438-25-000122 005-92738 25622170 34 11041
2025-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-001487 005-92738 25594552 34 11957
2025-01-30 8-K 8-K 7.01,9.01 0001558370-25-000526 001-40674 25571181 34 205755 1 1
2025-01-29 4 xslF345X05/form4-01292025_090107.xml 0001415889-25-002263 9216
2025-01-14 4 xslF345X05/form4.xml 0000905148-25-000092 4733
2025-01-13 8-K 8-K 2.02,9.01 0001558370-25-000151 001-40674 25524808 34 193377 1 1
2024-12-30 4 xslF345X05/form4-12302024_041201.xml 0001415889-24-030230 9218
2024-12-27 8-K 8-K 5.02,7.01,9.01 0001558370-24-016493 001-40674 241586012 34 205038 1 1
2024-12-26 144 xsl144X01/primary_doc.xml 0001972481-24-000330 001-40674 241581275 33 7042
2024-12-10 4 xslF345X05/form4-12102024_041201.xml 0001415889-24-028839 22212
2024-12-09 8-K 8-K 2.05,7.01,9.01 0001558370-24-016085 001-40674 241533894 34 195625 1 1
2024-11-13 SC 13G/A form_sc13ga-maxcyte.htm 0001011438-24-000634 005-92738 241456309 34 166941
2024-11-08 SC 13G/A us57777k1060_110824.txt 0002012383-24-004073 005-92738 241442098 34 13948
2024-11-06 10-Q 10-Q 0001558370-24-014662 001-40674 241431915 34 6139129 1 1
2024-11-06 8-K 8-K 2.02,7.01,9.01 0001558370-24-014641 001-40674 241431380 34 4539798 1 1
2024-11-05 4 xslF345X05/form4-11052024_041101.xml 0001415889-24-026144 9283
2024-10-31 SC 13G/A MXCT_SC13GA1_October2024.htm 0001319244-24-000054 005-92738 241415573 34 95779
2024-10-30 4 xslF345X05/form4-10302024_041006.xml 0001415889-24-025749 9216
2024-10-21 SC 13G/A us57777k1060_102124.txt 0002012383-24-000870 005-92738 241383501 34 13934
2024-10-16 4 xslF345X05/form4.xml 0000905148-24-002726 7066
2024-10-16 3 xslF345X02/form3.xml 0000905148-24-002724 13547
2024-10-15 8-K 8-K 5.02,7.01,9.01 0001558370-24-013318 001-40674 241372334 34 209258 1 1
2024-10-02 4 xslF345X05/form4-10022024_091036.xml 0001415889-24-024454 14980
2024-09-30 4 xslF345X05/form4-09302024_040901.xml 0001415889-24-024090 9216
2024-09-26 144 xsl144X01/primary_doc.xml 0001972481-24-000247 001-40674 241329073 33 6404
2024-09-18 4 xslF345X05/form4.xml 0000905148-24-002566 7258
2024-09-18 3 xslF345X02/form3.xml 0000905148-24-002564 18784
2024-09-05 4 xslF345X05/form4-09052024_090936.xml 0001415889-24-022941 14980
2024-09-03 144 xsl144X01/primary_doc.xml 0001972481-24-000216 001-40674 241274603 33 4518
2024-08-28 4 xslF345X05/form4-08282024_040806.xml 0001415889-24-022448 9215
2024-08-06 10-Q 10-Q 0001558370-24-011120 001-40674 241180220 34 5967622 1 1
2024-08-06 8-K 8-K 2.02,7.01,9.01 0001558370-24-011088 001-40674 241179413 34 4550901 1 1
2024-08-05 4 xslF345X05/form4-08052024_100803.xml 0001415889-24-020785 14907
2024-07-30 4 xslF345X05/form4-07302024_080732.xml 0001415889-24-020343 9217
2024-07-10 4 xslF345X05/form4-07102024_040702.xml 0001415889-24-019463 14911
2024-07-01 4 xslF345X05/form4-07012024_090717.xml 0001415889-24-018635 12883
2024-06-27 144 xsl144X01/primary_doc.xml 0001972481-24-000162 001-40674 241079578 33 5081
2024-06-24 4 xslF345X05/form4-06242024_080648.xml 0001415889-24-017956 9177
2024-06-20 144 xsl144X01/primary_doc.xml 0001972481-24-000157 001-40674 241056551 33 4553
2024-06-13 4 xslF345X05/form4-06132024_090602.xml 0001415889-24-016716 7375
2024-06-13 4 xslF345X05/form4-06132024_090638.xml 0001415889-24-016715 7499
2024-06-13 4 xslF345X05/form4-06132024_090609.xml 0001415889-24-016713 7332
2024-06-13 4 xslF345X05/form4-06132024_090659.xml 0001415889-24-016711 7341
2024-06-13 4 xslF345X05/form4-06132024_090651.xml 0001415889-24-016710 7397
2024-06-13 4 xslF345X05/form4-06132024_090639.xml 0001415889-24-016709 7389
2024-06-13 4 xslF345X05/form4-06132024_090610.xml 0001415889-24-016708 7383
2024-06-13 4 xslF345X05/form4-06132024_090617.xml 0001415889-24-016706 7364
2024-06-12 8-K 8-K 5.02,5.07,9.01 0001558370-24-009097 001-40674 241038970 34 444403 1 1
2024-06-10 4 xslF345X05/form4-06102024_090649.xml 0001415889-24-016259 7230
2024-05-07 10-Q 10-Q 0001558370-24-007085 001-40674 24923002 34 5008253 1 1
2024-05-07 8-K 8-K 2.02,7.01,9.01 0001558370-24-007051 001-40674 24922035 34 4966487 1 1
2024-05-01 ARS ARS 0001104659-24-055744 001-40674 24903323 34 2706036
2024-04-26 DEF 14A DEF 14A 0001104659-24-053089 001-40674 24885228 34 1410350
2024-03-28 4 xslF345X05/form4-03282024_040349.xml 0001415889-24-009334 9255
2024-03-25 SC 13G MXCT_SC13G_March2024.htm 0001319244-24-000032 005-92738 24779716 34 95865
2024-03-19 4 xslF345X05/form4-03192024_100327.xml 0001415889-24-008640 7659
2024-03-19 4 xslF345X05/form4-03192024_100311.xml 0001415889-24-008638 14402
2024-03-19 4 xslF345X05/form4-03192024_100330.xml 0001415889-24-008636 7670
2024-03-12 10-K 10-K 0001558370-24-003001 001-40674 24743115 34 17699542 1 1
2024-03-12 8-K 8-K 2.02,9.01 0001558370-24-002986 001-40674 24742157 34 599325 1 1
2024-03-05 8-K 8-K 2.02,9.01 0001558370-24-002480 001-40674 24720573 34 210774 1 1
2024-03-04 3 xslF345X02/form3.xml 0000905148-24-000859 15210
2024-02-28 4 xslF345X05/form4-02282024_040201.xml 0001415889-24-005727 9257
2024-02-26 144 xsl144X01/primary_doc.xml 0001972481-24-000045 001-40674 24679192 33 6995
2024-02-14 SC 13G/A d10974101_13g-a.htm 0000919574-24-001485 005-92738 24638952 34 126801
2024-02-14 SC 13G form_sc13g-maxcyte.htm 0001011438-24-000245 005-92738 24634960 34 174723
2024-02-13 SC 13G SCHEDULE 13G 0001104659-24-021436 005-92738 24628963 34 13119
2024-02-01 SC 13G/A MXCT_SC13GA.htm 0001319244-24-000020 005-92738 24587299 34 95904
2024-01-30 4 xslF345X05/form4-01302024_040101.xml 0001415889-24-001975 9296
2024-01-26 8-K 8-K 5.02,9.01 0001558370-24-000593 001-40674 24568574 34 289921 1 1
2024-01-26 SC 13G/A us57777k1060_012624.txt 0001086364-24-004307 005-92738 24565797 34 13636
2024-01-08 8-K 8-K 2.02,9.01 0001558370-24-000136 001-40674 24520310 34 199458 1 1
2024-01-04 4 FORM 4 SUBMISSION 0001209191-24-000790 6076
2023-12-28 4 FORM 4 SUBMISSION 0001209191-23-059910 9456
2023-12-11 8-K 8-K 5.02,7.01,9.01 0001558370-23-019718 001-40674 231478533 34 227138 1 1
2023-12-06 4 FORM 4 SUBMISSION 0001209191-23-057600 15297
2023-12-01 4 FORM 4 SUBMISSION 0001209191-23-057093 14787
2023-11-29 4 FORM 4 SUBMISSION 0001209191-23-056908 9349
2023-11-29 144 xsl144X01/primary_doc.xml 0001972481-23-000141 001-40674 231452799 33 4442
2023-11-17 SC 13G MXCT_SC13G.htm 0001319244-23-000062 005-92738 231418566 34 95762
2023-11-16 4 FORM 4 SUBMISSION 0001209191-23-055540 13392
2023-11-14 144 xsl144X01/primary_doc.xml 0001972481-23-000129 001-40674 231407430 33 6878
2023-11-08 10-Q 10-Q 0001558370-23-018314 001-40674 231389221 34 5626426 1 1
2023-11-08 8-K 8-K 2.02,9.01 0001558370-23-018276 001-40674 231387977 34 528226 1 1
2023-10-04 8-K 8-K 2.02,9.01 0001558370-23-016235 001-40674 231308060 34 195751 1 1
2023-08-30 4 FORM 4 SUBMISSION 0001209191-23-047756 20630
2023-08-09 10-Q 10-Q 0001558370-23-014306 001-40674 231156024 34 5261331 1 1
2023-08-09 8-K 8-K 2.02,9.01 0001558370-23-014270 001-40674 231155375 34 503276 1 1
2023-07-28 4 FORM 4 SUBMISSION 0001209191-23-043689 9461
2023-07-12 4 FORM 4 SUBMISSION 0001209191-23-042110 21145
2023-07-10 144 xsl144X01/primary_doc.xml 0001972481-23-000039 001-40674 231080332 33 8776
2023-06-28 4 FORM 4 SUBMISSION 0001209191-23-040058 19149
2023-06-26 144 xsl144X01/primary_doc.xml 0001972481-23-000028 001-40674 231042818 33 4865
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039486 5558
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039484 5525
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039480 5501
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039477 5643
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039471 5493
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039457 5544
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039455 5549
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039452 5535
2023-06-23 8-K FORM 8-K 5.02,5.07,9.01 0001104659-23-074068 001-40674 231035113 34 487069 1 1
2023-06-15 4 FORM 4 SUBMISSION 0001209191-23-037358 15299
2023-05-10 10-Q 10-Q 0001558370-23-009167 001-40674 23907531 34 4588613 1 1
2023-05-10 8-K 8-K 2.02,9.01 0001558370-23-009107 001-40674 23906531 34 453043 1 1
2023-05-05 4 FORM 4 SUBMISSION 0001209191-23-027781 9444
2023-04-28 ARS ARS 0001104659-23-053037 001-40674 23866918 34 2873990
2023-04-28 DEF 14A DEF 14A 0001104659-23-053015 001-40674 23866748 34 2268276
2023-04-12 4 FORM 4 SUBMISSION 0001209191-23-024116 20005
2023-04-12 4 FORM 4 SUBMISSION 0001209191-23-024097 20633
2023-04-07 4 FORM 4 SUBMISSION 0001209191-23-023809 15186
2023-04-07 4 FORM 4 SUBMISSION 0001209191-23-023806 15293
2023-04-04 4 FORM 4 SUBMISSION 0001209191-23-022988 20699
2023-04-04 4 FORM 4 SUBMISSION 0001209191-23-022983 20627
2023-03-30 4 FORM 4 SUBMISSION 0001209191-23-021573 5194
2023-03-28 4 FORM 4 SUBMISSION 0001209191-23-021333 5621
2023-03-28 3 FORM 3 SUBMISSION 0001209191-23-021332 6899
2023-03-28 8-K FORM 8-K 5.02,7.01,9.01 0001104659-23-037467 001-40674 23766586 34 408231 1 1
2023-03-21 4 FORM 4 SUBMISSION 0001209191-23-020298 5590
2023-03-21 4 FORM 4 SUBMISSION 0001209191-23-020293 5629
2023-03-21 4 FORM 4 SUBMISSION 0001209191-23-020291 5694
2023-03-21 4 FORM 4 SUBMISSION 0001209191-23-020289 5596
2023-03-21 4 FORM 4 SUBMISSION 0001209191-23-020287 5610
2023-03-21 4 FORM 4 SUBMISSION 0001209191-23-020285 5598
2023-03-21 4 FORM 4 SUBMISSION 0001209191-23-020283 8596
2023-03-15 10-K 10-K 0001558370-23-003911 001-40674 23736017 34 10754809 1 1
2023-03-15 8-K 8-K 2.02,9.01 0001558370-23-003872 001-40674 23735362 34 549307 1 1
2023-03-06 8-K 8-K 2.02,9.01 0001558370-23-002942 001-40674 23709777 34 205022 1 1
2023-02-14 SC 13G/A NONE 0001567619-23-002717 005-92738 23623938 34 113088
2023-02-13 SC 13G/A SC 13G/A 0001104659-23-019496 005-92738 23616907 34 191670
2023-02-03 4 FORM 4 SUBMISSION 0001209191-23-006880 19203
2023-02-03 4 FORM 4 SUBMISSION 0001209191-23-006876 15266
2023-01-31 SC 13G/A us57777k1060_013123.txt 0001306550-23-005157 005-92738 23571829 34 13404
2023-01-10 SC 13G/A d9912260_13g-a.htm 0000919574-23-000214 005-92738 23521684 34 128634
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-001995 21159
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-001980 21041
2022-12-06 4 FORM 4 SUBMISSION 0001209191-22-060077 15546
2022-12-02 144 xsl144X01/primary_doc.xml 0000919574-22-006945 001-40674 221439942 33 11217
2022-12-01 4 FORM 4 SUBMISSION 0001209191-22-059200 5625
2022-12-01 3 FORM 3 SUBMISSION 0001209191-22-059198 6810
2022-12-01 8-K FORM 8-K 5.02,7.01,9.01 0001104659-22-123467 001-40674 221437458 34 256732 1 1
2022-12-01 144 xsl144X01/primary_doc.xml 0000919574-22-006935 001-40674 221436829 33 10653
2022-11-30 144 xsl144X01/primary_doc.xml 0000919574-22-006922 001-40674 221434102 33 9999
2022-11-22 144 xsl144X01/primary_doc.xml 0000919574-22-006862 001-40674 221407124 33 9343
2022-11-21 144 xsl144X01/primary_doc.xml 0000919574-22-006851 001-40674 221403142 33 8686
2022-11-18 144 xsl144X01/primary_doc.xml 0000919574-22-006838 001-40674 221400280 33 8031
2022-11-17 144 xsl144X01/primary_doc.xml 0000919574-22-006816 001-40674 221396597 33 7377
2022-11-16 144 xsl144X01/primary_doc.xml 0000919574-22-006796 001-40674 221392620 33 6720
2022-11-10 144 xsl144X01/primary_doc.xml 0000919574-22-006358 001-40674 221374316 33 6134
2022-11-09 10-Q 10-Q 0001558370-22-017204 001-40674 221373543 34 6115463 1 1
2022-11-09 8-K 8-K 2.02,9.01 0001558370-22-017166 001-40674 221372804 34 475580 1 1
2022-11-09 144 xsl144X01/primary_doc.xml 0000919574-22-006300 001-40674 221370467 33 5380
2022-11-03 4 FORM 4 SUBMISSION 0001209191-22-055528 19233
2022-10-12 4 FORM 4 SUBMISSION 0001209191-22-053456 15181
2022-10-05 4 xslF345X03/ownership.xml 0000919574-22-005788 10602
2022-08-10 10-Q 10-Q 0001558370-22-013091 001-40674 221152596 34 6511045 1 1
2022-08-10 8-K 8-K 2.02,9.01 0001558370-22-013073 001-40674 221152017 34 536446 1 1
2022-07-14 S-8 FORM S-8 0001104659-22-079885 333-266133 221083392 33 210061
2022-07-08 4 FORM 4 SUBMISSION 0001209191-22-041614 5529
2022-07-08 4 FORM 4 SUBMISSION 0001209191-22-041612 5614
2022-07-08 4 FORM 4 SUBMISSION 0001209191-22-041609 5496
2022-07-08 4 FORM 4 SUBMISSION 0001209191-22-041608 5472
2022-07-08 4 FORM 4 SUBMISSION 0001209191-22-041607 5464
2022-07-08 4 FORM 4 SUBMISSION 0001209191-22-041606 5520
2022-07-08 4 FORM 4 SUBMISSION 0001209191-22-041605 5506
2022-07-06 4 xslF345X03/ownership.xml 0000919574-22-004059 10598
2022-06-30 8-K FORM 8-K 5.02,5.07,9.01 0001104659-22-076335 001-40674 221058515 34 481506 1 1
2022-05-26 DEF 14A DEF14A 0001140361-22-020805 001-40674 22970704 34 2401581
2022-05-09 10-Q 10-Q 0001558370-22-007869 001-40674 22905955 34 4935559 1 1
2022-05-09 8-K 8-K 2.02,9.01 0001558370-22-007826 001-40674 22905129 34 474008 1 1
2022-04-29 10-K/A FORM 10-K/A 0001104659-22-053626 001-40674 22876038 34 637708 1 1
2022-04-12 8-K FORM 8-K 2.02,5.02,9.01 0001104659-22-045082 001-40674 22822551 34 227826 1 1
2022-03-29 4 FORM 4 SUBMISSION 0001209191-22-021481 5565
2022-03-29 4 FORM 4 SUBMISSION 0001209191-22-021474 5579
2022-03-29 4 FORM 4 SUBMISSION 0001209191-22-021470 5547
2022-03-29 4 FORM 4 SUBMISSION 0001209191-22-021464 5581
2022-03-29 4 FORM 4 SUBMISSION 0001209191-22-021460 5567
2022-03-22 10-K 10-K 0001558370-22-004081 001-40674 22760680 34 11775149 1 1
2022-03-22 8-K 8-K 2.02,9.01 0001558370-22-004073 001-40674 22759689 34 568962 1 1
2022-03-17 3 FORM 3 SUBMISSION 0001209191-22-019610 6832
2022-02-15 SC 13G NONE 0001567619-22-004584 005-92738 22638487 34 112995
2022-02-11 SC 13G SC 13G 0001104659-22-020087 005-92738 22617699 34 199737
2022-02-04 SC 13G us57777k1060_020422.txt 0000834237-22-007285 005-92738 22593538 34 13373
2022-01-24 8-K FORM 8-K 2.02,9.01 0001104659-22-006977 001-40674 22550191 34 234699 1 1
2021-11-23 4 FORM 4 SUBMISSION 0001209191-21-066289 5163
2021-11-16 4 FORM 4 SUBMISSION 0001209191-21-064891 24952
2021-11-16 4 FORM 4 SUBMISSION 0001209191-21-064884 21167
2021-11-16 4 FORM 4 SUBMISSION 0001209191-21-064881 20503
2021-11-16 4 FORM 4 SUBMISSION 0001209191-21-064878 20507
2021-11-16 4 FORM 4 SUBMISSION 0001209191-21-064875 20529
2021-11-10 10-Q 10-Q 0001558370-21-015534 001-40674 211397499 34 6125776 1 1
2021-11-10 8-K FORM 8-K 2.02,9.01 0001104659-21-136950 001-40674 211396810 34 365179 1 1
2021-11-02 8-K FORM 8-K 5.07 0001104659-21-133041 001-40674 211371801 34 209081 1 1
2021-10-01 8-K FORM 8-K 5.02 0001104659-21-121662 001-40674 211297212 34 201613 1 1
2021-10-01 DEF 14A DEF 14A 0001104659-21-121580 001-40674 211297067 34 1872650
2021-09-17 8-K FORM 8-K 2.02,9.01 0001104659-21-116945 001-40674 211260863 34 479549 1 1
2021-09-13 10-Q 10-Q 0001558370-21-012432 001-40674 211250083 34 6163896 1 1
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050952 5388
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050949 5578
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050948 5596
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050945 5580
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050942 5517
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050940 5531
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050938 5562
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050936 5475
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050935 5483
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050931 5625
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050928 5582
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050926 5507
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050925 5540
2021-08-05 S-8 S-8 0001104659-21-100846 333-258524 211149621 33 85231
2021-08-04 8-K FORM 8-K 5.03,9.01 0001104659-21-100067 001-40674 211144016 34 166665
2021-08-03 4 xslF345X03/ownership.xml 0000919574-21-004808 10599
2021-08-03 SC 13G d8913977_13-g.htm 0000919574-21-004806 005-92738 211141023 34 126710
2021-07-30 424B4 424B4 0001104659-21-098238 333-257810 211132575 33 5385445
2021-07-30 3 xslF345X02/ownership.xml 0000919574-21-004774 9680
2021-07-29 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-07-29 16:30:00 9999999995-21-002983 333-257810 211129872 33 1809
2021-07-29 S-1MEF S-1MEF 0001104659-21-097793 333-258281 211129480 33 67901
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048677 15716
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048675 15423
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048674 9679
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048672 14669
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048670 14830
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048668 14847
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048666 16021
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048665 8168
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048663 15804
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048662 12178
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048659 16049
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048658 13777
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048655 8240
2021-07-29 CERT 8A_cert_MXCT.pdf 0001354457-21-000876 001-40674 211126044 34 751364
2021-07-27 CORRESP filename1.htm 0001104659-21-096338 14652
2021-07-27 CORRESP filename1.htm 0001104659-21-096333 8710
2021-07-27 8-A12B 8-A12B 0001104659-21-095955 001-40674 211115297 34 17353
2021-07-26 S-1/A S-1/A 0001104659-21-095556 333-257810 211112247 33 6960037
2021-07-09 CORRESP filename1.htm 0001104659-21-090684 25414
2021-07-09 S-1 S-1 0001104659-21-090682 333-257810 211083306 33 6248211
2021-07-08 UPLOAD filename1.pdf 0000000000-21-008464 42875
2021-06-25 DRSLTR filename1.htm 0001104659-21-085729 51176
2021-06-25 DRS/A filename1.htm 0001104659-21-085712 377-04865 211047781 33 6253870
2021-06-10 UPLOAD filename1.pdf 0000000000-21-007209 57849
2021-05-14 DRS filename1.htm 0001104659-21-066196 377-04865 21921638 33 5453624
2016-09-29 D xslFormDX01/primary_doc.xml 06b 0001287098-16-000003 021-271559 161909790 33 12693
2014-12-16 D xslFormDX01/primary_doc.xml 06b 0001488138-14-000004 021-230245 141289590 33 13356
2009-10-13 D/A xslFormDX01/primary_doc.xml 06 0001287098-09-000004 021-64601 091116238 33 13674
2009-08-31 D xslFormDX01/primary_doc.xml 06 0001287098-09-000003 021-64601 091046013 33 13885
2008-09-18 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-08-040423 021-64601 08060723 34 1469
2007-10-30 REGDEX/A AUTO-GENERATED PAPER DOCUMENT 06 9999999997-07-046710 021-64601 07081937 34 1475
2006-10-10 REGDEX/A AUTO-GENERATED PAPER DOCUMENT 06 9999999997-06-043774 021-64601 06060522 34 1475
2006-04-25 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-06-018246 021-64601 06034358 34 1469
2005-04-28 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-05-023041 021-64601 05052923 34 1469
2004-04-14 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-04-018218 021-64601 04025514 1413

Latest XBRL company facts

One latest value per concept from companyfacts (240 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 103.25M 2026-11-06 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
dei EntityPublicFloat Entity Public Float USD 230.70M 2025-06-30 2025 FY 10-K 2026-03-25 0001104659-26-034557
ffd NetFeeAmt NetFeeAmt USD 110.48 2026-04-14 S-8 2026-04-15 0001104659-26-043814
ffd TtlFeeAmt TtlFeeAmt USD 110.48 2026-04-14 S-8 2026-04-15 0001104659-26-043814
ffd TtlOfferingAmt TtlOfferingAmt USD 800,000 2026-04-14 S-8 2026-04-15 0001104659-26-043814
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-04-14 S-8 2026-04-15 0001104659-26-043814
srt StockRepurchaseProgramAuthorizedAmount1 StockRepurchaseProgramAuthorizedAmount1 USD 10.00M 2026-05-31 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.03M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 12.05M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 1.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 5.94M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 17.90M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 435.23M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 963,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 3.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 130,000 2023-12-31 2023 FY 10-K 2024-03-12 0001558370-24-003001
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 6,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 51,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 17.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap Assets Assets USD 182.48M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap AssetsCurrent Assets, Current USD 124.67M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrent Assets Held-for-sale, Not Part of Disposal Group, Current USD 180,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 27,300 2021-12-31 2022 Q1 10-Q 2022-05-09 0001558370-22-007869
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 2,400 2022-03-31 2022 Q1 10-Q 2022-05-09 0001558370-22-007869
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 241.47M 2022-03-31 2022 Q1 10-Q 2022-05-09 0001558370-22-007869
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 241.47M 2022-03-31 2022 Q1 10-Q 2022-05-09 0001558370-22-007869
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 25,000 2025-09-30 2025 Q3 10-Q 2025-11-13 0001104659-25-111396
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 29,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 541,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 13.37M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 13.37M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -6.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights GBP/shares 1.091 2019-11-30 2022 FY 10-K 2023-03-15 0001558370-23-003911
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 71,168 2019-11-30 2022 FY 10-K 2023-03-15 0001558370-23-003911
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 400.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 107.49M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 103.23M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap CommonStockValue Common Stock, Value, Issued USD 1.07M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -18.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 7.70M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 3.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 64,603 2021-08-01 2021-08-31 2022 Q3 10-Q 2022-11-09 0001558370-22-017204
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 4.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap CostOfRevenue Cost of Revenue USD 2.42M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001558370-21-015534
us-gaap DebtSecuritiesHeldToMaturityAllowanceForCreditLoss Debt Securities, Held-to-maturity, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-15 0001558370-23-003911
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -9.94M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap DeferredOtherTaxExpenseBenefit Deferred Other Tax Expense (Benefit) USD 11.81M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 7.39M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 344,600 2022-09-30 2022 Q3 10-Q 2022-11-09 0001558370-22-017204
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -1.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 945,000 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 39.50M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 29.50M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 13.24M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 9.64M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 1.40M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 66.54M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 1.01M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap Depreciation Depreciation USD 2.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 2.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 2.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.17 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.17 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.279 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent pure -0.017 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.028 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.018 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD -550,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002721
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 3.79M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 4.04M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 645,400 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-15 0001558370-23-003911
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 7,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-15 0001558370-23-003911
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 0 2026-03-31 2026 Q1 10-Q 2026-05-13 0001104659-26-060290
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 100,000 2020-12-31 2021 FY 10-K 2022-03-22 0001558370-22-004081
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 142,200 2020-12-31 2021 FY 10-K 2022-03-22 0001558370-22-004081
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 203,100 2021-06-30 2021 Q2 10-Q 2021-09-13 0001558370-21-012432
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 110,800 2021-06-30 2021 Q2 10-Q 2021-09-13 0001558370-21-012432
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 36,900 2021-06-30 2021 Q2 10-Q 2021-09-13 0001558370-21-012432
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 55,400 2021-06-30 2021 Q2 10-Q 2021-09-13 0001558370-21-012432
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 10,300 2021-06-30 2021 Q2 10-Q 2021-09-13 0001558370-21-012432
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 66,100 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-15 0001558370-23-003911
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 0 2026-03-31 2026 Q1 10-Q 2026-05-13 0001104659-26-060290
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 55,600 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-15 0001558370-23-003911
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 104,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap FinitelivedIntangibleAssetsAcquired1 Finite-lived Intangible Assets Acquired USD 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 853,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 749,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 215,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -23,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 19.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap Goodwill Goodwill USD 3.55M 2025-09-30 2025 Q3 10-Q 2025-11-13 0001104659-25-111396
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-06 0001558370-25-010554
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 3.55M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap GrossProfit Gross Profit USD 22.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 630,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -18.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-22 0001558370-22-004081
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 12.47M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 1.07M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002721
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -9.37M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount USD 746,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 1.24M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 796,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 299,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002721
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -2.56M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002721
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -2.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 8.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 3.52M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 3.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 708,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -1.12M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0001558370-22-007869
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -1.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 48,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -498,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 749,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap InterestCostsCapitalized Interest Costs Capitalized USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001558370-21-015534
us-gaap InterestExpense Interest Expense USD 5,400 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-15 0001558370-23-003911
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 420,900 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-15 0001558370-23-003911
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 3.41M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap InventoryNet Inventory, Net USD 7.38M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 3.41M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 1.16M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 564,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap InventoryWriteDown Inventory Write-down USD 400,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 4.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap LeaseCost Lease, Cost USD 2.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 22.86M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 9.79M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.71M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 2.52M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 2.46M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.40M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 2.34M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 662,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 5.97M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap Liabilities Liabilities USD 31.55M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 182.48M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap LiabilitiesCurrent Liabilities, Current USD 15.92M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap LongTermInvestments Long-term Investments USD 31.47M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 4.92M 2020-12-31 2021 FY 10-K 2022-03-22 0001558370-22-004081
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -5.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 17.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -18.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -18.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap NumberOfReportingUnits Number of Reporting Units item 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap OperatingExpenses Operating Expenses USD 44.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -22.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap OperatingLeaseLeaseIncome Operating Lease, Lease Income USD 11.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 16.89M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.56M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 15.32M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 10.24M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 683,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.071 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap OtherAssetsCurrent Other Assets, Current USD 3.54M 2021-09-30 2021 Q3 10-Q 2021-11-10 0001558370-21-015534
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.01M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 311,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 4.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 5.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 260,000 2021-03-01 2021-03-31 2022 FY 10-K 2023-03-15 0001558370-23-003911
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 17.56M 2021-08-03 2024 Q3 10-Q 2024-11-06 0001558370-24-014662
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 1.77M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 150,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 55.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 193,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 255.09M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001558370-24-003001
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.78M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 184.30M 2021-08-03 2023 Q3 10-Q 2023-11-08 0001558370-23-018314
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 1.60M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-09 0001558370-23-014306
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 34,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity GBP 40.20M 2021-02-01 2021-02-28 2022 FY 10-K 2023-03-15 0001558370-23-003911
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 313.77M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0001558370-24-003001
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 1.44M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-22 0001558370-22-004081
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 72.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 9,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002721
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 29,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -18.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 14.34M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap PropertyPlantAndEquipmentTransfersAndChanges Property, Plant and Equipment, Transfers and Changes USD 475,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 29,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 4.92M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-15 0001558370-23-003911
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 10.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap RestructuringCharges Restructuring Charges USD 3.06M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -279.87M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 15.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 449,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap Revenues Revenues USD 27.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 956,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 51.80M 2021-02-01 2021-02-28 2022 FY 10-K 2023-03-15 0001558370-23-003911
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 11.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap SeveranceCosts1 Severance Costs USD 3.06M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 3.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 76,000 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 10.98M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 5.9 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 906,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 3,327 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002721
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 2.57M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.43M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 76,000 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 13.57M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 5.44 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.28 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 6.46 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-11 0001558370-25-002721
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 5.94 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 3.15 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 13 2021-08-03 2023 Q3 10-Q 2023-11-08 0001558370-23-018314
us-gaap SharesOutstanding Shares, Outstanding shares 106.79M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap ShortTermInvestments Short-term Investments USD 87.91M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 8,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 150.93M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 130,646 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 15.53M 2021-08-03 2023 Q3 10-Q 2023-11-08 0001558370-23-018314
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures shares 609,460 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 338,419 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 1.09M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-15 0001558370-23-003911
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 34,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 51.81M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-15 0001558370-23-003911
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 24,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 Stock Repurchase Program, Remaining Authorized Repurchase Amount USD 4.50M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034557
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 4.26M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 5.50M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired shares 4.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 5.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap VariableLeaseCost Variable Lease, Cost USD 1.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 105.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 105.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125236

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →